Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
11/2010
11/09/2010CA2434028C Amino ceramide-like compounds and therapeutic methods of use
11/09/2010CA2407659C Growth hormone secretagogues
11/09/2010CA2380070C New derivatives of hydantoines, thiohydantoine, pyrimidinediones and thioxopyrimidinones, their preparation methods and their application as medications
11/04/2010WO2010126169A1 Pharmaceutical composition for preventing vascular disorders which comprises alk1 inhibitor as active ingredient
11/04/2010WO2010126167A1 Thiophene derivative
11/04/2010WO2010126164A1 Indole-2-carboxamide derivative
11/04/2010WO2010126163A1 Heteroarylthiomethyl pyridine derivative
11/04/2010WO2010126104A1 4-substituted pyridazinone compound and p2x7 receptor inhibitor
11/04/2010WO2010126022A1 Imidazole derivative
11/04/2010WO2010125831A1 Sulfamoyl benzoic acid derivatives as trpm8 antagonists
11/04/2010WO2010125799A1 Urea derivative having pi3k inhibitory activity
11/04/2010WO2010124520A1 Pharmaceutical composition for treating abnormal energy metabolism and use thereof
11/04/2010WO2010095808A3 Production method for astragalus membranaceus extract employing enzymolysis, and a composition for preventing or alleviating diabetes or obesity containing an active ingredient comprising an astragalus membranaceus extract produced by means of the production method
11/04/2010WO2010068863A3 Pyrimidine compounds and methods of making and using same
11/04/2010WO2010068287A3 Small molecule modulators of hepatocyte growth factor (scatter factor) activity
11/04/2010US20100280249 Synthesis of 4-amino-thalidomide enantiomers
11/04/2010US20100280131 Methods for the inhibition of atrophy or for treatment or prevention of atrophy-related symptoms in women
11/04/2010US20100280107 Treating benign prostate hyperplasia with sarms
11/04/2010US20100280087 Novel 2-amino benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels
11/04/2010US20100280080 Medicaments
11/04/2010US20100280076 Derivatives of dioxan-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
11/04/2010US20100280074 Ccr9 inhibitors and methods of use thereof
11/04/2010US20100280065 Perharidines as cdk inhibitors
11/04/2010US20100280045 Novel compounds
11/04/2010US20100280016 Pyrazoline compounds
11/04/2010US20100279961 Pharmaceutical composition having a trihydroxy-chromenone derivative
11/04/2010US20100279958 Compounds and methods for inhibiting selectin-mediated function
11/04/2010US20100279327 Method of treating diseases with parp inhibitors
11/04/2010US20100278909 Process for forming solid oral dosage forms of angiotensin ii receptor antagonists
11/04/2010US20100278843 Agents and methods for modulating macrophage inhibitory cytokine (mic-1) activity
11/04/2010US20100278817 Compounds and methods for the treatment of renal disease
11/04/2010US20100278786 Use of the opposite cell differentiation program (ocdp) for the treatment of degenerated organs in the pathological state
11/04/2010US20100278727 Alpha-Emitting constructs and uses thereof
11/04/2010CA2760451A1 Compositions and methods for treating and preventing overactive bladder and conditions associated therewith
11/04/2010CA2760387A1 Thiophene derivative
11/04/2010CA2759471A1 Heteroarylthiomethyl pyridine derivative
11/04/2010CA2757761A1 Sulfamoyl benzoic acid derivatives as trpm8 antagonists
11/03/2010EP2246360A1 Compositions for the treatment of gastrointestinal disorders
11/03/2010EP2246344A1 Pyrimidine compounds and medicinal composition thereof
11/03/2010EP2246066A1 Use of neurotoxin therapy for treatment of urologic and related disorders
11/03/2010EP2246052A1 Orally rapidly disintegrating tablet comprising imidafenacin
11/03/2010EP2246051A1 Method for production of orally rapidly disintegrating tablet comprising imidafenacin as active ingredient
11/03/2010EP2245067A2 Methods of using cadherin 11 (cdh11) antagonists
11/03/2010EP1556080B1 Furin inhibitors for use in the treatment of fibrosis and scarring
11/03/2010EP1496838B1 Substituted amides
11/03/2010EP1469834B1 Multi-stage oral drug controlled-release system
11/03/2010EP1296929B1 Modified forms of pharmacologically active agents and uses therefor
11/03/2010CN1951390B Pharmaceutical compositions comprising colloidal silicon dioxide
11/03/2010CN1938226B Method for producing spherical activated carbon
11/03/2010CN1899404B Compound patrinia preparation and preparing method
11/03/2010CN1872062B Fibrauretine, and preparation method
11/03/2010CN1806832B Pharmaceutical composition, its preparation process and quality control method
11/03/2010CN101878028A Medium-chain length fatty acids and glycerides as nephroprotection agents
11/03/2010CN101875894A Making method of wine for tonifying kidney and strengthening yang
11/03/2010CN101874845A Quality control method for Chinese medicinal preparation for treating urinary infection
11/03/2010CN101874824A Active extract containing trilobatin and application thereof
11/03/2010CN101874801A Application of pyridine compounds in preparing medicaments for treating diabetic nephropathy
11/03/2010CN101874800A Medicament for treating chronic interstitial nephritis
11/03/2010CN101874792A Phloroglucinol orally disintegrating tablets and preparation method thereof
11/03/2010CN101249229B Chinese medicine preparation for curing bloody stranguria type cystitis
11/02/2010US7825255 Adenosine receptor selective modulators
11/02/2010US7825219 Binding protein; therapy for bone tumors
11/02/2010US7825146 Sulfonamide derivative having isoxazole ring
11/02/2010CA2484542C Method for the inhibition of atrophy or for treatment or prevention of atrophy-related symptoms in women
11/02/2010CA2471521C Novel microsphere and method for production thereof
11/02/2010CA2470391C N,n'-disubstituted piperazine compounds and their use as analgesics
11/02/2010CA2462799C Pyrimidine derivatives
11/02/2010CA2458740C Method of treating systemic inflammatory response syndrome
11/02/2010CA2437715C Carboline derivatives
11/02/2010CA2417432C Modified polypeptides stabilized in a desired conformation and methods for producing same
11/02/2010CA2407466C Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype
10/2010
10/28/2010WO2010123006A1 Pyrrolidine compound
10/28/2010WO2010121980A1 Use of nifuratel to treat infections caused by atopobium species
10/28/2010US20100273862 Phosphatases which activate map kinase pathways
10/28/2010US20100273854 Compositions and methods for inhibiting nadph oxidase expression
10/28/2010US20100273849 Metalloproteinase Inhibitors
10/28/2010US20100273825 Solid pharmaceutical composition containing solifenacin amorphous form
10/28/2010US20100273783 Compositions and Methods for Treating and Preventing Overactive Bladder and Conditions Associated Therewith
10/28/2010US20100273766 Substituted oxindol derivatives, medicaments containing said derivatives and use thereof
10/28/2010US20100273709 Composition Comprising Desmopressin
10/28/2010US20100272812 Rgd-modified alginate microparticles as a drug release system
10/28/2010US20100272811 Complex of trospium and pharmaceutical compositions thereof
10/28/2010US20100272806 Compositions and Methods for Treating and Preventing Urolithiasis and Conditions Associated Therewith
10/28/2010US20100272789 External medicine for treatment or prevention
10/28/2010US20100272754 Botulinum toxin administration to treat various conditions
10/28/2010CA2755328A1 Use of nifuratel to treat infections caused by atopobium species
10/27/2010EP2243779A1 Bicyclic heterocyclic derivative
10/27/2010EP2243776A1 Substituted piperidines and their use for the treatment of diseases related to the histamine H3 receptor
10/27/2010EP2243486A1 Adrenomedullin production enhancer
10/27/2010EP2243482A1 Use of nifuratel to treat infections caused by atopobium species
10/27/2010EP2242499A1 Compositions for the treatment of benign prostate hypertrophy, prostatitis, prostatosis and prostate cancer
10/27/2010EP1432408B1 Pharmaceutical compositions comprising colloidal silicon dioxide
10/27/2010EP1330293B2 Controlled release composition comprising lactic acid polymer, and method of producing the same
10/27/2010EP1218509B9 Fibroblast growth factor-like polypeptides
10/27/2010EP1112088B1 Method for detecting connective tissue growth factor for diagnosing a renal disorder
10/27/2010CN1678317B 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related compounds as neurokinin-1(NK-1) antagonists for the treatment of emesis, depression, anxiety and cough
10/27/2010CN1585640B N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation
10/27/2010CN101869710A Antihypertensive medical composite
10/27/2010CN101869684A Traditional Chinese medicine for tonifying kidney
10/27/2010CN101869645A Jinkui kidney qi-replenishing traditional Chinese medicine solid oral preparation and preparation method thereof
1 ... 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 ... 562